Created in 1993, InGen has become one of the market leaders in French in vitro diagnostics, particularly well known in the fields of infectious diseases and immunology. The quality of its products and support contribute to the company's reputation.

The company covers a wide range of disciplines in order to offer 'turn-key' solutions to medical teams in the following fields:

  • Bacteriology
  • Virology
  • Parasitology
  • Mycology
  • Auto-immunity
  • Hormonology
  • Quality control
  • Transplants
  • Genetic diseases

InGen was bougth in 2006 by the biotechnology company IBS (ex AbAg), specialised in serology and proteomics, thus integrating the InGen BioSciences group.

In 2012, Exonhit has acquired the InGen BioSciences group to establish the Diaxonhit group InGen remaining specialized in the distribution of IVDMD.